Risk factors associated with mortality in hospitalized patients with SARS-CoV-2 infection. A prospective, longitudinal, unicenter study in Reus, Spain
S. Iftimie, A. F. Lopez-Azcona, M. Vicente-Miralles, R. Descarrega-Reina, A. Hernandez-Aguilera, F. Riu, J. M. Simo, P. Garrido, J. Joven, J. Camps, A. Castro
Abstract
Spain is one of the countries that has suffered the most from the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the strain that causes coronavirus disease 2019 (COVID-19). However, there is a lack of information on the characteristics of this disease in the Spanish population. The objective of this study has been to characterize our patients from an epidemiological point of view and to identify the risk factors associated with mortality in our geographical area. We performed a prospective, longitudinal study on 188 hospitalized cases of SARS-Cov-2 infection in Hospital Universitari de Sant Joan, in Reus, Spain, admitted between 15th March 2020 and 30th April 2020. We recorded demographic data, signs and symptoms and comorbidities. We also calculated the Charlson and McCabe indices. A total of 43 deaths occurred during the study period. Deceased patients were older than the survivors (77.7 {+/-} 13.1 vs. 62.8 {+/-} 18.4 years; p < 0.001). Logistic regression analyses showed that fever, pneumonia, acute respiratory distress syndrome, diabetes mellitus and cancer were the variables that showed independent and statistically significant associations with mortality. The Charlson index was more efficient than the McCabe index in discriminating between deceased and survivors. This is one of the first studies to describe the factors associated with mortality in patients infected with SARS-CoV-2 in Spain, and one of the few in the Mediterranean area. We identified the main factors independently associated with mortality in our population. Further studies in are needed to complete and confirm our findings.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Development and validation of a clinical risk score to predict the risk of SARS-CoV-2 infection from administrative data: a population-based cohort study from Italy
V. Orlando, F. Rea, … G. Corrao·PLOS ONEPeer-reviewed·Jan 20, 2021
- Diet Induced Obesity and Diabetes Enhance Mortality and Reduces Vaccine Efficacy for SARS-CoV-2
R. Johnson, J. Ardunay, … M. Frieman·bioRxiv·Oct 15, 2022
- MORTALITY-ASSOCIATED SARS-COV-2 GENOMIC VARIANTS FROM PATIENTS HOSPITALIZED FOR SEVERE PNEUMONIA IN AGUASCALIENTES, MEXICO FROM 2020 TO 2023
Brian Muñoz Gomez, Sarahí Lozano-Gamboa, … Corina Diana Ceapă·bioRxiv·Mar 5, 2024
- A national analysis of trends in COVID-19 infection and clinical management in Veterans Health Administration medical facilities
M. Aboumrad, B. Shiner, … Y. Young-Xu·bioRxiv·Jan 18, 2021
- Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality
Tomoko Nakanishi, Sara Pigazzini, … Andrea Ganna·Journal of Clinical InvestigationPeer-reviewed·Oct 1, 2021
- Follow-up of a hospital cohort during the first 3,530 suspected cases of COVID-19 in Sao Jose do Rio Preto, Sao Paulo, Brazil
Carolina Colombelli Pacca, Nathália Zini, … Cássia Fernanda Estofolete·bioRxiv·Feb 4, 2021